Antihypertensive, antialbuminuric and metabolic effects of manidipine + lisinopril and manidipine, amlodipine, or telmisartan in non-diabetic hypertensive patients with metabolic syndrome
Phase of Trial: Phase IV
Latest Information Update: 20 Jun 2011
At a glance
- Drugs Amlodipine (Primary) ; Lisinopril (Primary) ; Manidipine (Primary) ; Telmisartan (Primary)
- Indications Essential hypertension; Metabolic syndrome
- Focus Pharmacodynamics
- Acronyms MARCADOR
- 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.
- 05 Nov 2010 New trial record.